Bacteria yield clues about why proteins go bad in ALS and Alzheimer's

Nov 02, 2012

(Phys.org)—Scientists are unsure why proteins form improperly and cluster together in bunches, a hallmark of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer's and Mad Cow Disease. In the Nov. 1 issue of the journal Molecular Cell, Yale scientists shed light on protein aggregate formation by studying the process in bacteria.

"The question we are all asking is what happens when protein synthesis goes wrong?" said Jesse Rinehart, assistant professor of cellular and molecular physiology at Yale's West Campus and co-senior author of the paper.

Proteins are created from instructions encoded in DNA and assembled in ribosomes within the cells. However, sometimes they are not assembled correctly, and these misfolded proteins tend to aggregate, a process typified by the plaques that form in the brains of Alzheimer's patients.

The Yale team—led by Rinehart and Dieter Söll, Sterling Professor of and Biochemistry and professor of chemistry—showed that the antibiotic streptomycin can trigger protein aggregations in the bacterium E. coli. Using large-scale proteomics and genetic screens, they analyzed the aggregates and searched for that make E. coli cells resistant to antibiotics and other threats. The researchers discovered how one of these proteins protecting the bacteria from also suppressed the aggregation of proteins triggered by streptomycin.

"The properties of these are still mysterious, but here we have a glimpse of how they form and how cells escape from these aggregates in bacteria," Söll said.

The study not only provides insight into how these protein aggregates can form, but illustrates how bacteria defend themselves against toxic threats. Such information could help scientists develop more effective antibiotics, Rinehart said.

Explore further: Researchers develop computational model to simulate bacterial behavior

Related Stories

Genetic code used to engineer a living protein

Aug 25, 2011

Yale University researchers have successfully re-engineered the protein-making machinery in bacteria, a technical tour de force that promises to revolutionize the study and treatment of a variety of diseases.

Cellular stress can induce yeast to promote prion formation

Jul 23, 2011

It's a chicken and egg question. Where do the infectious protein particles called prions come from? Essentially clumps of misfolded proteins, prions cause neurodegenerative disorders, such as mad cow/Creutzfeld-Jakob disease, ...

Neurodegeneration 'clumping proteins' common in aging process

Aug 10, 2010

Many proteins that form insoluble clumps in the brains of people with Alzheimer's and other neurodegenerative diseases are also found in healthy individuals and clump together as a normal part of aging. According to a surprising ...

New discoveries in cell aging

Jan 23, 2012

A group of researchers led by the Institute of Biotechnology and Biomedicine (IBB) and Universitat Autònoma de Barcelona (UAB) have achieved to quantify with precision the effect of protein aggregation on cell aging ...

Recommended for you

Compound from soil microbe inhibits biofilm formation

8 hours ago

Researchers have shown that a known antibiotic and antifungal compound produced by a soil microbe can inhibit another species of microbe from forming biofilms—microbial mats that frequently are medically harmful—without ...

Researcher among best in protein modeling contests

11 hours ago

A Purdue University researcher ranks among the best in the world in bioinformatics competitions to predict protein structure, docking and function, making him a triple threat in the world of protein modeling.

Survey of salmonella species in Staten Island Zoo's snakes

12 hours ago

For humans, Salmonella is always bad news. The bacterial pathogen causes paratyphoid fever, gastroenteritis and typhoid. But for snakes, the bacteria aren't always bad news. Certain species of Salmonella are a natural part ...

A long-standing mystery in membrane traffic solved

Mar 27, 2015

In 2013, James E. Rothman, Randy W. Schekman, and Thomas C. Südhof won the Nobel Prize in Physiology or Medicine for their discoveries of molecular machineries for vesicle trafficking, a major transport ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.